286 related articles for article (PubMed ID: 12176681)
1. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
3. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis.
Majoie IM; Oldhoff JM; van Weelden H; Laaper-Ertmann M; Bousema MT; Sigurdsson V; Knol EF; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Am Acad Dermatol; 2009 Jan; 60(1):77-84. PubMed ID: 19103360
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study.
Breuckmann F; von Kobyletzki G; Avermaete A; Kreuter A; Altmeyer P
Photodermatol Photoimmunol Photomed; 2002 Oct; 18(5):217-22. PubMed ID: 12390661
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy.
Breuckmann F; von Kobyletzki G; Avermaete A; Kreuter A; Altmeyer P; Gambichler T
BMC Dermatol; 2002 Aug; 2():12. PubMed ID: 12204095
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of UVA1 phototherapy on the expression of bcl-2 and p53 in atopic dermatitis.
Breuckmann F; Pieck C; Kreuter A; Bacharach-Buhles M; Mannherz HG; Altmeyer P; von Kobyletzki G
Arch Dermatol Res; 2001 Apr; 293(4):178-83. PubMed ID: 11380150
[TBL] [Abstract][Full Text] [Related]
7. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy.
Schnopp C; Rad R; Weidinger A; Weidinger S; Ring J; Eberlein B; Ollert M; Mempel M
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):81-5. PubMed ID: 17523929
[TBL] [Abstract][Full Text] [Related]
8. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
[TBL] [Abstract][Full Text] [Related]
9. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
[TBL] [Abstract][Full Text] [Related]
10. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis.
Tzaneva S; Seeber A; Schwaiger M; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2001 Oct; 45(4):503-7. PubMed ID: 11568738
[TBL] [Abstract][Full Text] [Related]
11. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
13. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
[TBL] [Abstract][Full Text] [Related]
15. [Langerhans cells in the physiopathology of atopic dermatitis].
Bieber T; Bruijnzeel-Koomen C
Ann Dermatol Venereol; 1990; 117(3):185-93. PubMed ID: 2193589
[TBL] [Abstract][Full Text] [Related]
16. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema.
Grabbe J; Welker P; Humke S; Grewe M; Schöpf E; Henz BM; Krutmann J
J Invest Dermatol; 1996 Sep; 107(3):419-22. PubMed ID: 8751980
[TBL] [Abstract][Full Text] [Related]
17. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
[TBL] [Abstract][Full Text] [Related]
19. Granulomatous slack skin responds to UVA1 phototherapy.
Oberholzer PA; Cozzio A; Dummer R; French LE; Hofbauer GF
Dermatology; 2009; 219(3):268-71. PubMed ID: 19546523
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
